Related Experiment Video
Updated: Apr 29, 2026

09:16
Use of a Video Scoring Anchor for Rapid Serial Assessment of Social Communication in Toddlers
Published on: March 14, 2018
13.0K
Application of the resource-based relative value scale system to pediatrics
Pediatrics
|May 28, 2014
Summary
Physician payment in the US relies on the Medicare Resource-Based Relative Value Scale (RBRVS). Concerns exist that RBRVS surveys may undervalue non-procedural services, impacting pediatrician compensation.
Area of Science:
- Health Economics
- Medical Policy
Background:
- The Medicare Resource-Based Relative Value Scale (RBRVS) is widely used by payers for physician payment in the U.S.
- Many practices use RBRVS to benchmark productivity and determine physician compensation.
- The RBRVS survey instrument was primarily designed for procedural services.
Purpose of the Study:
- To address concerns that current RBRVS surveys may undervalue non-procedural evaluation and management services.
- To advocate for appropriate physician work relative value unit (RVU) assignments for pediatric services.
Main Methods:
- The American Academy of Pediatrics participates in the American Medical Association/Specialty Society Relative Value Scale Update Committee (RUC).
- The Academy collaborates with other medical societies to ensure balanced RUC membership.
- Advocacy for a revised survey instrument to accurately value physician services.
Main Results:
- Current RBRVS survey design may lead to undervaluation of non-procedural services.
- The RUC is responsible for maintaining accurate physician work values across specialties.
- Pediatricians may not receive appropriate payment relative to other medical services.
Conclusions:
- Ensuring appropriate RVU assignments is crucial for fair pediatrician reimbursement.
- Active participation in the RUC and collaboration with other societies are key to addressing undervaluation.
- A balanced RUC and improved survey instruments are needed for equitable physician payment.
Related Concept Videos
Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Relative Risk
2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
960
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960
Pharmacokinetics in Pediatric Patients: Drug Excretion
404
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404
Pharmacokinetics in Pediatric Patients: Drug Distribution
552
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Pharmacokinetics in Pediatric Patients: Drug Metabolism
409
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409

